Patent directory · USPTO A61K / A61P
Patents matching “Takeda Pharmaceutical Company Limited”
1,022 pharma patents match "Takeda Pharmaceutical Company Limited" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,022 pharmaceutical patents matching "Takeda Pharmaceutical Company Limited" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 8273751
Organic compounds
granted -
US 8268819
Hexahydrooxazinopterine compounds
granted -
US 8263121
Solid pharmaceutical preparation
granted -
US 8258252
Sustained-release composition and process for producing the same
granted -
US 8252814
Agents and crystals for improving excretory potency of urinary bladder
granted -
US 8246987
Controlled release composition and method of producing the same
granted -
US 8247403
Benzoxazepine derivatives and use thereof
granted -
US 8247429
Tricyclic compound and pharmaceutical use thereof
granted -
US 8236837
Tricyclic compound and pharmaceutical use thereof
granted -
US 8222411
Dipeptidyl peptidase inhibitors
granted -
US 8222422
Crystal of benzimidazole compound
granted -
US 8217176
Fused heterocyclic derivative and use thereof
granted -
US 8212046
Process for producing crystal
granted -
US 8202990
Polo-like kinase inhibitors
granted -
US 8188275
Dipeptidyl peptidase inhibitors
granted -
US 8183285
Therapeutic agent for irritable bowel syndrome and methods thereof
granted -
US 8183212
Compound having GPR54 agonistic activity
granted -
US 8178543
Bi- and tricyclic fused pyrimidines as tyrosine kinase inhibitors
granted -
US 8178555
Apoptosis signal-regulating kinase 1 inhibitors
granted -
US 8178534
cMET inhibitors
granted -
US 8173663
Dipeptidyl peptidase inhibitors
granted -
US 8173360
Cell death inhibitor
granted -
US 8163755
Hexahydrooxazinopterine compounds
granted -
US 8163935
Fused heterocyclic compounds
granted